Literature DB >> 26465782

Industry Bias in Randomized Controlled Trials in General and Abdominal Surgery: An Empirical Study.

Pascal Probst1, Phillip Knebel, Kathrin Grummich, Solveig Tenckhoff, Alexis Ulrich, Markus W Büchler, Markus K Diener.   

Abstract

BACKGROUND: Industry sponsorship has been identified as a source of bias in several fields of medical science. To date, the influence of industry sponsorship in the field of general and abdominal surgery has not been evaluated.
METHODS: A systematic literature search (1985-2014) was performed in the Cochrane Library, MEDLINE, and EMBASE to identify randomized controlled trials in general and abdominal surgery. Information on funding source, outcome, and methodological quality was extracted. Association of industry sponsorship and positive outcome was expressed as odds ratio (OR) with 95% confidence interval (CI). A χ test and a multivariate logistic regression analysis with study characteristics and known sources of bias were performed.
RESULTS: A total of 7934 articles were screened and 165 randomized controlled trials were included. No difference in methodological quality was found. Industry-funded trials more often presented statistically significant results for the primary endpoint (OR, 2.44; CI, 1.04-5.71; P = 0.04). Eighty-eight of 115 (76.5%) industry-funded trials and 19 of 50 (38.0%) non-industry-funded trials reported a positive outcome (OR, 5.32; CI, 2.60-10.88; P < 0.001). Industry-funded trials more often reported a positive outcome without statistical justification (OR, 5.79; CI, 2.13-15.68; P < 0.001). In a multivariate analysis, funding source remained significantly associated with reporting of positive outcome (P < 0.001).
CONCLUSIONS: Industry funding of surgical trials leads to exaggerated positive reporting of outcomes. This study emphasizes the necessity for declaration of funding source. Industry involvement in surgical research has to ensure scientific integrity and independence and has to be based on full transparency.

Mesh:

Year:  2016        PMID: 26465782     DOI: 10.1097/SLA.0000000000001372

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  24 in total

1.  Effect of early administration of coagulation factor XIII on fistula after pancreatic surgery: the FIPS randomized controlled trial.

Authors:  Yoshinori Takeda; Yoshihiro Mise; Naoki Ishizuka; Sohei Harada; Brian Hayama; Yosuke Inoue; Takeaki Ishizawa; Hiromichi Ito; Yu Takahashi; Akio Saiura
Journal:  Langenbecks Arch Surg       Date:  2018-11-30       Impact factor: 3.445

Review 2.  Journal impact factor and methodological quality of surgical randomized controlled trials: an empirical study.

Authors:  Usama Ahmed Ali; Beata M M Reiber; Joren R Ten Hove; Pieter C van der Sluis; Hein G Gooszen; Marja A Boermeester; Marc G Besselink
Journal:  Langenbecks Arch Surg       Date:  2017-06-04       Impact factor: 3.445

3.  2D vs. 3D imaging in laparoscopic surgery-results of a prospective randomized trial.

Authors:  Alexander Buia; Florian Stockhausen; Natalie Filmann; Ernst Hanisch
Journal:  Langenbecks Arch Surg       Date:  2017-10-06       Impact factor: 3.445

Review 4.  Optimal literature search for systematic reviews in surgery.

Authors:  Käthe Goossen; Solveig Tenckhoff; Pascal Probst; Kathrin Grummich; André L Mihaljevic; Markus W Büchler; Markus K Diener
Journal:  Langenbecks Arch Surg       Date:  2017-12-05       Impact factor: 3.445

5.  Conception of the Lübeck Toolbox curriculum for basic minimally invasive surgery skills.

Authors:  Tilman Laubert; Hamed Esnaashari; Paul Auerswald; Anna Höfer; Michael Thomaschewski; Hans-Peter Bruch; Tobias Keck; Claudia Benecke
Journal:  Langenbecks Arch Surg       Date:  2017-12-01       Impact factor: 3.445

Review 6.  Effectiveness of Tachosil(®) in the prevention of postoperative pancreatic fistula after distal pancreatectomy: a systematic review and meta-analysis.

Authors:  Felix J Hüttner; André L Mihaljevic; Thilo Hackert; Alexis Ulrich; Markus W Büchler; Markus K Diener
Journal:  Langenbecks Arch Surg       Date:  2016-02-20       Impact factor: 3.445

7.  Training or non-surgical factors-what determines a good surgical performance? A randomised controlled trial.

Authors:  Cornelia Lindlohr; R Lefering; S Saad; M M Heiss; C Pape-Köhler
Journal:  Langenbecks Arch Surg       Date:  2017-02-25       Impact factor: 3.445

8.  Testing Distinct Three-Dimensional Effects in Laparoscopy: A Prospective Randomized Trial Using the Lübecker Toolbox Curriculum.

Authors:  Michael Thomaschewski; Thorsten Jürgens; Claudia Benecke; Anna-Catherina Griesmann; Hamed Esnaashari; Romy Lux; Diana Scheppan; Ronja Simon; Tobias Keck; Tilman Laubert
Journal:  Visc Med       Date:  2020-02-24

9.  Pre-Emptive Endoluminal Negative Pressure Therapy at the Anastomotic Site in Minimally Invasive Transthoracic Esophagectomy (the preSPONGE Trial): Study Protocol for a Multicenter Randomized Controlled Trial.

Authors:  Philip C Müller; Diana Vetter; Joshua R Kapp; Christoph Gubler; Bernhard Morell; Dimitri A Raptis; Christian A Gutschow
Journal:  Int J Surg Protoc       Date:  2021-03-18

10.  Characteristics of Randomized Clinical Trials in Surgery From 2008 to 2020: A Systematic Review.

Authors:  N Bryce Robinson; Stephen Fremes; Irbaz Hameed; Mohamed Rahouma; Viola Weidenmann; Michelle Demetres; Mahmoud Morsi; Giovanni Soletti; Antonino Di Franco; Marco A Zenati; Shahzad G Raja; David Moher; Faisal Bakaeen; Joanna Chikwe; Deepak L Bhatt; Paul Kurlansky; Leonard N Girardi; Mario Gaudino
Journal:  JAMA Netw Open       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.